1419 — Human Health Holdings Cashflow Statement
0.000.00%
- HK$299.85m
- -HK$47.83m
- HK$590.82m
- 99
- 92
- 11
- 79
Annual cashflow statement for Human Health Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -39 | 169 | 445 | 239 | 26.6 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 24.5 | 7.21 | -13.2 | 71.1 | -6.06 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -23.3 | -158 | -199 | 280 | -75.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 37.5 | 85.5 | 296 | 664 | 13.2 |
Capital Expenditures | -11.5 | -14.1 | -76.5 | -84 | -39.5 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -7.52 | 9.28 | -127 | -251 | -8.13 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -19 | -4.77 | -203 | -335 | -47.6 |
Financing Cash Flow Items | -4.66 | -2.87 | -2.83 | -7.93 | -7.86 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -64.7 | -59.3 | -67.4 | -178 | -125 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -46.4 | 22 | 25 | 149 | -159 |